- Why Work With NSF?
NSF Pharma Biotech has helped companies that have been placed on import alert and have had their products subject to detention without physical examination (DWPE). We can determine what conditions are causing the import alert and assist your company with the remediation of these conditions. In addition, we can interface with the agency with your approval to help better understand the actions required to lift the import alert.
For more information about NSF Pharma Biotech regulatory enforcement action support in the U.S., email email@example.com or call +1 202.822.1850.
For more information about NSF Pharma Biotech regulatory enforcement action support in Europe, email firstname.lastname@example.org or call +44 1751 432 999.
Why Work With NSF?
Our team includes former U.S. FDA inspectors and experts who have a proven track record for addressing the most complex regulatory problems and compliance issues. We can interface with the agency on your behalf to help you to better understand the actions needed to lift the import ban.
- 3 days ago
FDA Regulatory and Compliance News FDA expanded the approved use of Eli Lily’s Cyramza (ramucirumab) to treat patients with metastatic...
- 1 week ago
FDA Regulatory and Compliance News FDA published a notice of a Privacy Act system of records entitled, “FDA Commissioning of...
- 2 months ago
ANN ARBOR, Mich. – Global public health organization NSF International and leaders from major retailers and manufacturers created the Global...
- Monday, January 5, 2015
- 1:00pm - 2:00pm GMT
- Webinar, United Kingdom
- Thursday, January 15, 2015
- 12:30pm - 5:00pm Central European Time
- Antwerp, Belgium
- Monday, January 19, 2015
- 8:30am - 5:00pm GMT
- York, United Kingdom
- Tuesday, February 3, 2015
- 8:30am - 3:00pm GMT
- Manchester, UK, United Kingdom